Matinas BioPharma Holdings Inc
MTNB0.692USD
+0.022+3.24%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
4.08MMarket Cap
LossP/E TTM
Matinas BioPharma Holdings Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
-100.00%
EPS(YoY)
-4.98
5.60%
Analyst Rating
2025-06-28
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of -100.00%.
What is the Earnings Per Share (EPS) of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -4.984, with a year-on-year change of 5.60%.
What is the net income of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its net income was -24.25M, with a year-on-year change of -5.71%.
What is the net margin of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its debt-to-asset ratio was 0.13%, with a year-on-year change of 46.78%.
What is the Return on Equity (ROE) of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its Return on Equity (ROE) was -180.73%, with a year-on-year change of -120.12%.
What is the Return on Assets (ROA) of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its Return on Assets (ROA) was -128.50%, with a year-on-year change of -95.82%.
What is the operating profit of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its operating profit was -20.16M, with a year-on-year change of 15.16%.
What are the current assets of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its current assets were 8.03M, with a year-on-year change of -48.37%.
What are the total assets of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its total assets of Matinas BioPharma Holdings Inc were 12.64M, with a year-on-year change of -49.65%.
What are the total liabilities of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its total liabilities of Matinas BioPharma Holdings Inc were 5.05M, with a year-on-year change of -13.78%.
What is the total equity of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its total equity of Matinas BioPharma Holdings Inc was 7.59M, with a year-on-year change of -60.56%.
What is the net operating income of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its net operating income of Matinas BioPharma Holdings Inc was -24.25M, with a year-on-year change of -5.71%.
What is the net investment of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its net investment of Matinas BioPharma Holdings Inc was 9.21M, with a year-on-year change of -30.46%.
What is the net financing of Matinas BioPharma Holdings Inc?
According to Matinas BioPharma Holdings Inc's FY2024 earnings report, its net financing of Matinas BioPharma Holdings Inc was 9.17M, with a year-on-year change of 131157.14%.
